Holly Hagan
#97,448
Most Influential Person Now
Researcher
Holly Hagan 's AcademicInfluence.com Rankings
Holly Hagan computer-science Degrees
Computer Science
#11050
World Rank
#11665
Historical Rank
Machine Learning
#5048
World Rank
#5111
Historical Rank
Artificial Intelligence
#5444
World Rank
#5519
Historical Rank
Database
#8079
World Rank
#8422
Historical Rank
Download Badge
Computer Science
Holly Hagan 's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Holly Hagan Influential?
(Suggest an Edit or Addition)According to Wikipedia, Holly Hagan is an American infectious disease epidemiologist and nurse. She is a full professor in the College of Global Public Health at New York University and director of the Center for Drug Use and HIV/HCV Research.
Holly Hagan 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (7185)
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) (4152)
- The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. (2013) (2142)
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition (2015) (1618)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1475)
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews (2011) (1252)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1241)
- Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial (1999) (555)
- Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 (2016) (549)
- A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. (2011) (317)
- Maintaining low HIV seroprevalence in populations of injecting drug users. (1995) (291)
- Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta‐analysis (2013) (276)
- Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. (2008) (223)
- Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis (2017) (216)
- Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs (2017) (212)
- Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. (2003) (212)
- Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men (2015) (203)
- Non-injection drug use and Hepatitis C Virus: a systematic review. (2007) (198)
- Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001 (2005) (184)
- Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. (2003) (174)
- Self-Reported Hepatitis C Virus Antibody Status and Risk Behavior in Young Injectors (2006) (166)
- A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users (2007) (154)
- Hepatitis C Virus Infection Among Injection Drug Users: Survival Analysis of Time to Seroconversion (2004) (149)
- Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. (2013) (141)
- Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City (2007) (140)
- Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. (2012) (137)
- Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. (2005) (120)
- “Informed Altruism” and “Partner Restriction” in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990–2001 (2004) (119)
- Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. (2010) (116)
- Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. (2012) (114)
- Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the beck depression inventory (2004) (107)
- Public health and changes in illicit drug prices. (2001) (98)
- HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. (2007) (96)
- High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. (2006) (93)
- Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. (2015) (93)
- Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. (2007) (92)
- Predictors of accidental fatal drug overdose among a cohort of injection drug users. (2001) (92)
- Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. (2014) (87)
- Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area (2000) (86)
- Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review. (2014) (78)
- The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. (2007) (77)
- Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. (2011) (75)
- HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. (2005) (74)
- Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). (2007) (72)
- Distributive syringe sharing among young adult injection drug users in five U.S. cities. (2007) (72)
- Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women. (2011) (69)
- A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. (2008) (67)
- Patterns of Exchange Sex and HIV Infection in High-Risk Heterosexual Men and Women (2011) (67)
- Young adult injection drug users in the United States continue to practice HIV risk behaviors. (2009) (66)
- Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18–30 Years, 1994–2004 (2007) (66)
- Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection (2008) (65)
- High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review (2013) (65)
- Reconsidering the Internet as an HIV/STD Risk for Men Who Have Sex with Men (2010) (64)
- Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. (2007) (64)
- Evaluating respondent-driven sampling in a major metropolitan area: Comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studies. (2010) (63)
- Changes in injection risk behavior associated with participation in the seattle needle-exchange program (2000) (59)
- Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. (2010) (57)
- Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. (2007) (56)
- Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis (2017) (55)
- Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. (2009) (55)
- Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. (2011) (54)
- Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services (2007) (54)
- Case-reporting of acute hepatitis B and C among injection drug users (2002) (50)
- Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs. (2016) (50)
- Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. (2006) (50)
- Recruitment-Adjusted Estimates of HIV Prevalence and Risk among Men Who Have Sex with Men: Effects of Weighting Venue-Based Sampling Data (2011) (47)
- A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. (2009) (47)
- Transitions from Injection-Drug-Use-Concentrated to Self-Sustaining Heterosexual HIV Epidemics: Patterns in the International Data (2012) (47)
- Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. (2009) (47)
- Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. (2006) (46)
- Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review. (2014) (46)
- Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. (2008) (46)
- Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis (2016) (44)
- Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs (2000) (43)
- Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA (2001) (42)
- Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. (2007) (42)
- HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. (2010) (41)
- Missed Opportunities for HIV Testing Among High-Risk Heterosexuals (2009) (40)
- Differences in the fecal microbiota of neonates born at home or in the hospital (2018) (40)
- Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia (2002) (40)
- Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. (2011) (39)
- Dual HIV Risk: Receptive Syringe Sharing and Unprotected Sex Among HIV-Negative Injection Drug Users in New York City (2013) (39)
- Gaps in the drug-free and methadone treatment program response to Hepatitis C. (2003) (39)
- Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: A systematic review and meta-analysis. (2017) (39)
- Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. (2006) (37)
- Syphilis in drug users in low and middle income countries. (2010) (34)
- The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection. (2014) (34)
- Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users (2006) (33)
- Peer-Education Intervention to Reduce Injection Risk Behaviors Benefits High-Risk Young Injection Drug Users: A Latent Transition Analysis of the CIDUS 3/DUIT Study (2012) (33)
- Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics (2008) (33)
- Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users. (2009) (33)
- Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. (2012) (30)
- The relevance of attributable risk measures to HIV prevention planning. (2003) (28)
- Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE) (2007) (28)
- Barriers and Facilitators to Undergoing Hepatitis C Virus (HCV) Testing through Drug Treatment Programs (2008) (27)
- Hepatitis C Knowledge among Staff in U.S. Drug Treatment Programs (2006) (27)
- Using a jail-based survey to monitor HIV and risk behaviors among seattle area injection drug users (2001) (27)
- Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations (2018) (26)
- Factors Associated with Recent HIV Testing Among Men Who Have Sex with Men in New York City (2013) (26)
- The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units (2004) (25)
- The HCV Synthesis Project: Scope, methodology, and preliminary results (2008) (25)
- Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City (2014) (25)
- Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial. (2011) (25)
- Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment (2017) (24)
- Estimated HIV Incidence Among High-Risk Heterosexuals in New York City, 2007 (2011) (24)
- Transitions from injecting to non-injecting drug use: potential protection against HCV infection. (2014) (24)
- Agent, host, and environment: hepatitis C virus in people who inject drugs. (2011) (24)
- Herpes Simplex Virus-2 and HIV Among Noninjecting Drug Users in New York City (2007) (23)
- Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysis (2014) (23)
- Emerging infectious diseases and the injection of illicit psychoactive drugs (1996) (23)
- 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs (2013) (23)
- Sexual Risk and HIV Infection Among Drug Users in New York City: A Pilot Study (2011) (22)
- On the way to Hepatitis C elimination in the Republic of Georgia—Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study (2019) (22)
- Sexual and injection-related risks in Puerto Rican-born injection drug users living in New York City: A mixed-methods analysis (2011) (22)
- Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005-2014. (2016) (22)
- A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. (2004) (22)
- Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units. (2005) (21)
- HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City (2014) (21)
- Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York City (2017) (21)
- Outpatient Drug Treatment Program Directors' Hepatitis C‐Related Beliefs and Their Relationship to the Provision of HCV Services (2004) (21)
- Does bleach disinfection of syringes help prevent hepatitis C virus transmission? (2003) (21)
- Strategies to uncover undiagnosed HIV infection among heterosexuals at high risk and link them to HIV care with high retention: a “seek, test, treat, and retain” study (2015) (20)
- A Perfect Storm: Crack Cocaine, HSV-2, and HIV Among Non-Injecting Drug Users in New York City (2014) (20)
- Multilevel Risk Factors for Greater HIV Infection of Black Men who Have Sex With Men in New York City (2014) (19)
- HIV/AIDS Prevention for Drug Users in Natural Settings (2000) (19)
- Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis. (2013) (19)
- Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis (2014) (19)
- High HIV prevalence among low-income, Black women in New York City with self-reported HIV negative and unknown status. (2013) (17)
- Reciprocal Sex Partner Concurrency and STDs among Heterosexuals at High-Risk of HIV Infection (2013) (16)
- Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for “Ending the Epidemic” (2016) (16)
- Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S. (2006) (16)
- Correlates of selling sex among male injection drug users in New York City. (2014) (16)
- Can intranasal drug use reduce HCV infection among injecting drug users? (2011) (16)
- Gender and Age Patterns in HSV-2 and HIV Infection Among Non-Injecting Drug Users in New York City (2010) (16)
- Spatial Recruitment Bias in Respondent-Driven Sampling: Implications for HIV Prevalence Estimation in Urban Heterosexuals (2014) (16)
- Illicit drug use and HIV risk in the Dominican Republic: Tourism areas create drug use opportunities (2015) (15)
- HTLV-2 infection in injection drug users in King County, Washington (2006) (15)
- Staff Perspectives on Facilitating the Implementation of Hepatitis C Services at Drug Treatment Programs (2006) (15)
- Estimating HIV Incidence and the Correlates of Recent Infection in Venue-Sampled Men Who Have Sex With Men in New York City (2012) (15)
- Continuing HIV Risk in New York City Injection Drug Users: The Association of Syringe Source and Syringe Sharing (2011) (14)
- Trends in HIV prevalence and risk behavior among men who have sex with men in New York City, 2004-2011. (2014) (14)
- Time Since Migration and HIV Risk Behaviors Among Puerto Ricans Who Inject Drugs in New York City (2016) (14)
- Community Sexual Bridging Among Heterosexuals at High-Risk of HIV in New York City (2016) (14)
- Drug Treatment Programs as Sites of Opportunity for the Delivery of Hepatitis C Prevention Education: Client and Staff Perspectives (2004) (14)
- Impact of the September 11th attacks in New York City on drug users: a preliminary assessment (2002) (13)
- The Interaction of Risk Network Structures and Virus Natural History in the Non-spreading of HIV Among People Who Inject Drugs in the Early Stages of the Epidemic (2017) (13)
- Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas (2010) (13)
- P2-416 Estimating the prevalence of hepatitis B infection among people who inject drugs: results from a global systematic review (2011) (12)
- Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005–2012 (2017) (12)
- Providing support to drug users infected with hepatitis C : The role of methadone maintenance treatment staff (2005) (12)
- HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection (2013) (12)
- Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs (2012) (11)
- Exploring Factors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection Recruited with Venue-based Sampling (2016) (11)
- Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis. (2018) (11)
- Experiences of Discrimination and HIV Risk Among Men Who Have Sex With Men in New York City (2016) (11)
- Transitions in Latent Classes of Sexual Risk Behavior Among Young Injection Drug Users Following HIV Prevention Intervention (2013) (11)
- Hepatitis B vaccination among research participants, Seattle, Washington. (2002) (10)
- Supervised injection rooms—prospects and limitations (2002) (10)
- Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs (2017) (10)
- Reply to “Invited Commentary: Needle Exchange—No Help for Hepatitis?” by Moss and Hahn (1999) (10)
- Preventing Epidemics of HIV-1 among Injecting Drug Users (1998) (9)
- The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysis (2016) (9)
- What happened to the HIV epidemic among non‐injecting drug users in New York City? (2017) (9)
- Explaining Racial/Ethnic Dietary Patterns in Relation to Type 2 Diabetes: An Analysis of NHANES 2007-2012. (2016) (9)
- Perceptions of genetic testing and genomic medicine among drug users. (2015) (8)
- From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits. (2016) (8)
- Racial and ethnic disparities in predictors of glycemia: a moderated mediation analysis of inflammation-related predictors of diabetes in the NHANES 2007–2010 (2018) (8)
- Correlates of Drug Treatment Program Staff's Self Efficacy to Support Their Clients' Hepatitis C Virus (HCV) Related Needs (2007) (8)
- Hepatitis C Service Delivery in Prisons: Peer Education From the “Guys in Blue” (2005) (8)
- Continuing Links Between Substance Use and HIV Highlight the Importance of Nursing Roles (2017) (7)
- Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection. (2005) (7)
- Hybrid STTR intervention for heterosexuals using anonymous HIV testing and confidential linkage to care: a single arm exploratory trial using respondent-driven sampling (2015) (7)
- Residential Substance User Treatment Programs as Venues for HCV Pharmacological Treatment: Client and Staff Perspectives (2005) (7)
- Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks (2021) (6)
- Recommended best practices for effective syringe exchange programs in the United States: Results of a consensus meeting (2010) (6)
- HCV (Hepatitis C Virus) Pre-Test and Post-Test Counseling Services at Drug Treatment Programs: Missed Opportunities for Primary Prevention (2005) (6)
- Use of the “NYC Condom” among People Who Use Drugs (2014) (6)
- Drug treatment programs' HCV service delivery to their HCV positive clients (2006) (5)
- Bisexual Behavior Among Male Injection Drug Users in New York City (2015) (5)
- Improved injection network ascertainment with supplementary elicitation techniques (2008) (4)
- Incidence of sexually tra nsmitted hepatitis C virus infection in HIV-positive MSM : a systematic review and meta-analysis (2015) (4)
- Sexual HIV/HSV-2 Risk Among Drug Users in New York City: An HIV Testing and Counseling Intervention (2013) (4)
- It's Never Just HIV: Exposure to an HIV Prevention Media Campaign and Behavior Change Among Men Who Have Sex with Men Participating in the National HIV Behavioral Surveillance System in New York City. (2016) (4)
- Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population. (2019) (4)
- Hepatitis C Among Intravenous Drug Users (2005) (4)
- Hepatitis C Virus Disease Progression in People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis (2015) (4)
- Current and Emerging Research Needs in Studying the NYC HIV–Drug Use Epidemic (2011) (3)
- Research Note: Perspectives on the Hierarchy of HIV and Hepatitis C Disease: Consequences for Drug Treatment Program Patients (2010) (2)
- Racial and ethnic data justice: The urgency of surveillance data disaggregation (2022) (2)
- The Tacoma Syringe Exchange studies: Public health practice influences research. (2003) (2)
- Participation of the nursing workforce to address COVID-19 among people who use alcohol, tobacco, and drugs (2020) (2)
- Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City? (2015) (2)
- Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus (2017) (2)
- A Randomized Clinical Trial of Pegylated Interferon for Acute Hepatitis C Virus Infection in Active Injection Drug Users (2014) (1)
- Drug Abuse and the Spread of Infection: HIV and AIDS as an Example (2005) (1)
- Maintaining Low HIV Seroprevalence Among Injecting Drug Users-Reply (1996) (1)
- Reply to Gyarmathy (2010) (1)
- Decline in HSV-2 among non-injecting Heroin and Cocaine users in New York City, 2005-2014: potential protection against HIV resurgence (2017) (0)
- Response to the calculation of population attributable fractions of risk factors for hepatitis C transmission: authors' reply. (2016) (0)
- Highly Active Antiretroviral Therapy for Injection Drug Users: Physician-Recommended Strategies for Enhanced Adherence (2003) (0)
- Erratum: Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities (Clinical Infectious Diseases (March 1, 2006) 42 (1118-1126)) (2006) (0)
- Epidemiology of Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis (2017) (0)
- METHADONE TKEATMENT AND HIV AND HEPATITIS 13 AND C KISK KEDLICTION AMONG INJECTOKS IN THE SEATTLE AKEA (2000) (0)
- Erratum: Correction to Lancet HIV ((2016) 3 (e361–87)(S235230181630087X)(10.1016/S2352-3018(16)30087-X) (2016) (0)
- Introduction: The New York HIV-Drug Use Epidemic: Lessons Learned and Unresolved Issues (2011) (0)
- Reply to “High-Quality Meta-Analyses Are Required for Development of Evidence in Medicine” (2012) (0)
- Differences in the fecal microbiota of neonates born at home or in the hospital (2018) (0)
- PersistenceandChangeinDisparitiesinHIVInfection AmongInjectionDrugUsersinNewYorkCityAfter Large-ScaleSyringeExchangePrograms (2009) (0)
- Application of an adapted PRECIS-2 instrument to assess efficacy- and effectiveness-study designs in a systematic review of intervention studies of the hepatitis C virus-care continuum among people who use drugs (2018) (0)
- UnprotectedAnalIntercourseandSexuallyTransmitted DiseasesinHigh-RiskHeterosexualWomen (2011) (0)
- Peer reviewers 2000 (2006) (0)
- ORIGINAL CONTRIBUTIONS Syringe Exchange and Risk of Infection with Hepatitis B and C Viruses (1999) (0)
- A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic (2022) (0)
- Hepatitis C virus infection among HIV-positivemen who have sex with men: protocol for asystematic review and meta-analysis (2014) (0)
- Studies of HIV/AIDS and injecting drug use. (1992) (0)
- FIVE OF THE AUTHORS REPLY (2000) (0)
- A peer-education intervention to reduce injection risk behaviors for HIV and HCV infection in young injection drug users. (2018) (0)
- Author Correction: Differences in the fecal microbiota of neonates born at home or in the hospital (2019) (0)
- AssociationsBetweenHerpesSimplexVirusType2andHCV WithHIVAmongInjectingDrugUsersinNewYorkCity:The CurrentImportanceofSexualTransmissionofHIV (2011) (0)
- Withdrawal Prevention Tactics Scale (2018) (0)
This paper list is powered by the following services:
Other Resources About Holly Hagan
What Schools Are Affiliated With Holly Hagan ?
Holly Hagan is affiliated with the following schools:
